Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bufei Huoxue Capsule for stable chronic obstructive pulmonary disease with osteoporosis
ChiCTR2300075114Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bufei huoxue in chronic obstructive pulmonary disease (COPD) and osteoporosis, sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Change in 6-minute walk distance at week 24 from baseline. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
bufei huoxue
03
Conditions
chronic obstructive pulmonary disease (COPD)osteoporosis
Beyond the preview
Go deeper on ChiCTR2300075114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075114.